Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Use this TBPH page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TBPH quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TBPH SEC filings page. Lician reads the product cache first so this HTML stays unique to Theravance Biopharma Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TBPH income, balance, and cash tables.